Nicotine and cannabis vaping among adolescents in treatment for substance use disorders
- PMID: 34016296
- PMCID: PMC8140195
- DOI: 10.1016/j.jsat.2021.108304
Nicotine and cannabis vaping among adolescents in treatment for substance use disorders
Abstract
This study examined nicotine and cannabis vaping among adolescents in treatment for substance use disorders. Participants were 363 adolescents aged 12-17 (66% male, mean age = 15.5 [SD = 1.3], 46% non-Hispanic white) seen for a specialty addiction intake evaluation between 2017 and 2019 at one of six medical offices of a large, integrated health care system in Northern California. Multivariable logistic regression models tested for associations of sociodemographics, cigarette smoking, and substance use disorders with vaping behaviors. A majority of adolescents reported ever (68%) or current vaping (60%) of nicotine and/or cannabis; current vaping was similar for nicotine (50%) and cannabis (51%); 40% reported current vaping of both. Current smokers (6% of the sample) had higher odds of ever vaping (aOR = 3.95, 95%CI: 1.04-14.95). Black (versus non-Hispanic white) adolescents had lower odds of current nicotine vaping (aOR = 0.08, 95%CI: 0.02-0.37) and current vaping of both nicotine and cannabis (aOR = 0.12, 95%CI: 0.03-0.60). Having an alcohol use disorder was associated with current vaping (aOR = 2.14, 95%CI: 1.06-4.33). Those who endorsed that most friends get drunk/high (aOR = 1.87, 95%CI: 1.02-3.42) or that cannabis was their substance of choice (aOR = 2.36, 95%CI: 1.16-4.81) had higher odds of current cannabis vaping. Higher neighborhood household income ($80,000-$120,000 and >$120,000 vs. <$80,000, aORs = 2.05-9.48), never versus ever blunt use (aORs = 2.47-8.68), and intakes in 2018 and 2019 versus 2017 (aORs = 2.18-5.38) were associated with higher odds of all vaping outcomes. Vaping was common among adolescents in addiction treatment and varied with sociodemographics and substance-related factors. Research should assess how vaping impacts the development of substance use disorders and whether it interferes with addiction treatment.
Keywords: Addiction treatment; Adolescents; Cannabis; E-cigarette; Nicotine; Vaping.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of Interest
JPP has provided consultation to pharmaceutical and technology companies that make medications and other treatments for quitting smoking and has served as an expert witness in lawsuits against the tobacco companies. The other authors declare that they have no financial relationships with any organizations that might have an interest in the submitted work. Other authors report no conflicts of interest.
Similar articles
-
Prevalence and Factors Associated With Vaping Cannabidiol Among US Adolescents.JAMA Netw Open. 2023 Aug 1;6(8):e2329167. doi: 10.1001/jamanetworkopen.2023.29167. JAMA Netw Open. 2023. PMID: 37585202 Free PMC article.
-
Assessment of Nicotine and Cannabis Vaping and Respiratory Symptoms in Young Adults.JAMA Netw Open. 2020 Dec 1;3(12):e2030189. doi: 10.1001/jamanetworkopen.2020.30189. JAMA Netw Open. 2020. PMID: 33351085 Free PMC article.
-
Association of Perceived Neighborhood Disorder with Substance Use Behaviors and Retail Access Among Southern California Adolescents.Subst Use Misuse. 2025;60(2):228-235. doi: 10.1080/10826084.2024.2422972. Epub 2024 Nov 4. Subst Use Misuse. 2025. PMID: 39497034
-
Detection of vaping, cannabis use, and hazardous prescription opioid use among adolescents.Lancet Child Adolesc Health. 2022 Nov;6(11):820-828. doi: 10.1016/S2352-4642(22)00212-7. Epub 2022 Aug 26. Lancet Child Adolesc Health. 2022. PMID: 36030794 Free PMC article. Review.
-
Cannabis Use Variations and Myocardial Infarction: A Systematic Review.J Clin Med. 2024 Sep 22;13(18):5620. doi: 10.3390/jcm13185620. J Clin Med. 2024. PMID: 39337107 Free PMC article. Review.
Cited by
-
Cannabis Vaping Among Youth and Young Adults: a Scoping Review.Curr Addict Rep. 2022;9(3):217-234. doi: 10.1007/s40429-022-00413-y. Epub 2022 May 7. Curr Addict Rep. 2022. PMID: 35573056 Free PMC article.
-
Cigarette Smoking During Recovery From Substance Use Disorders.JAMA Psychiatry. 2025 Aug 13:e251976. doi: 10.1001/jamapsychiatry.2025.1976. Online ahead of print. JAMA Psychiatry. 2025. PMID: 40802176
-
The history, evolution, and practice of cannabis and E-cigarette industries highlight necessary public health and public safety considerations.J Safety Res. 2023 Feb;84:192-203. doi: 10.1016/j.jsr.2022.10.019. Epub 2022 Nov 11. J Safety Res. 2023. PMID: 36868647 Free PMC article. No abstract available.
-
Racial and Ethnic Differences in Cannabis Use and Cannabis Use Disorder: Implications for Researchers.Curr Addict Rep. 2022 Mar;9(1):14-22. doi: 10.1007/s40429-021-00404-5. Epub 2022 Jan 5. Curr Addict Rep. 2022. PMID: 35251891 Free PMC article.
-
E-cigarette vaping associated acute lung injury (EVALI): state of science and future research needs.Crit Rev Toxicol. 2022 Mar;52(3):188-220. doi: 10.1080/10408444.2022.2082918. Epub 2022 Jul 13. Crit Rev Toxicol. 2022. PMID: 35822508 Free PMC article. Review.
References
-
- American Lung Association. (2020). E-cigarette or vaping use-associated lung injury (EVALI). https://www.lung.org/lung-health-diseases/lung-disease-lookup/evali. Accessed September 30, 2020.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical